These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2622019)

  • 1. [Clinical significance of von Willebrand factor analysis in blood coagulo-fibrinolytic tests].
    Takahashi Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():853-7. PubMed ID: 2622019
    [No Abstract]   [Full Text] [Related]  

  • 2. [von Willebrand factor (antigen and activity), multimer structure, and ristocetin cofactor activity].
    Goto S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():643-6. PubMed ID: 15658412
    [No Abstract]   [Full Text] [Related]  

  • 3. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand's disease.
    Rick ME
    Clin Lab Med; 1994 Dec; 14(4):781-94. PubMed ID: 7874871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 10. von Willebrand's Disease.
    Zimmerman TS; Ruggeri ZM
    Clin Haematol; 1983 Feb; 12(1):175-200. PubMed ID: 6404576
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing mild hemophilia A from von Willebrand's syndrome.
    Sabo MG; Triplett DA; Peden JC
    Am J Med Technol; 1978 May; 44(5):455-63. PubMed ID: 307909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic strategies for detection of the von Willebrand syndrome].
    Eller T; Mayer J; Bomhard M; Keller F
    Beitr Infusionsther; 1992; 30():268-71. PubMed ID: 1284714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [von Willebrand syndrome].
    Scharrer I
    Behring Inst Mitt; 1986 Feb; (79):12-23. PubMed ID: 3487311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [von Willebrand disease].
    Meyer D; Chassigneux J
    Rev Prat; 1989 Dec; 39(30):2679-83. PubMed ID: 2515582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.
    Brosstad F; Kjønniksen I; Rønning B; Stormorken H
    Thromb Haemost; 1986 Apr; 55(2):276-8. PubMed ID: 3520939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods of measurement of Willebrand activity on microtitration plates].
    Sultan Y; Rossi J
    Nouv Presse Med; 1977 Jan; 6(1):44-6. PubMed ID: 299940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study on two methods of quantitative assay for von Willebrand factor using a washed-platelet-system and a fixed-washed-platelet-system (author's transl)].
    Kajikawa M; Taketomi Y; Ihara A; Nakagawa J; Fujimura K
    Rinsho Ketsueki; 1976 Aug; 17(8):868-75. PubMed ID: 1088552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spectrum of von Willebrand-Jürgens syndrome. A study on 53 patients].
    Hasler K; Klink I
    Dtsch Med Wochenschr; 1985 Oct; 110(40):1531-4. PubMed ID: 3930195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.